There is a lack of robust evidence on the benefits of self-monitoring in patients newly diagnosed with Type 2 diabetes. This was investigated in the DESMOND Self Monitoring Study, a cluster randomised controlled trial comparing the effectiveness of self monitoring of blood glucose and urinalysis in patients attending the DESMOND Newly Diagnosed education course
The study was a multi-site randomised controlled trial run in 8 PCTs around England. Study participants attended a DESMOND Newly Diagnosed patient course which included an additional one hour session on self-monitoring using either blood glucose testing or urine testing. Three Educators in every Primary Care Trust were trained to deliver the courses. We would like to thank them for their help with the study. Just under 300 newly diagnosed patients were recruited to the study and collection of follow-up data is complete. The results are being prepared for submission.
The study was funded by Diabetes UK and the Principal Investigator is Professor Simon Heller, University of Sheffield. For more information please contact Dr Helen Dallosso (email@example.com;0116 2584738)